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Summary As chromosomes 2p and 3p are frequent targets for genomic instability in lung cancer, we have addressed whether alterations of
simple (CA), DNA repeats occur in non-small-cell lung cancer (NSCLC) at early stages. We have analysed by polymerase chain reaction
(PCR) assay replication errors (RER) and loss of heterozygosity (LOH) at microsatellites mapped on chromosomes 2p and 3p in 64 paired
tumour-normal DNA samples from consecutively resected stage 1, 11 or IIIA NSCLC. DNA samples were also examined for K-ras and p53
gene mutations by PCR-single-stranded conformational polymorphism (PCR-SSCP) analysis and cyclic sequencing, as well as their
relationship with clinical outcome. Forty-two of the 64 (66%) NSCLC patients showed RER at single or multiple loci. LOH was detected in 23
tumours (36%). Among patients with stage I disease, the 5-year survival rate was 80% in those whose tumours had no evidence of RER and
26% in those with RER (P = 0.005). No correlation was established between RER phenotype and LOH, K-ras or p53 mutations. RER
remained a strong predictive factor (hazard ratio for death, 2.89; 95% confidence interval, 2.23-3.79; P= 0.002) after adjustment for all other
evaluated factors, including p53, K-ras, LOH, histological type, tumour differentiation and TNM stage, suggesting that microsatellite instability
on chromosomes 2p and 3p may play a role in NSCLC progression through a different pathway from the traditional tumour mechanisms of
oncogene activation and/or tumour-suppressor gene inactivation.
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Two fundamental genetic mechanisms, activation of proto-
oncogenes and inactivation of tumour-suppressor genes, appear
to account for the genesis of most, if not all, human cancers.
Consequently, DNA alterations in NSCLC have previously been
found to occur at different chromosomal loci containing both
oncogenes, such as ras (Rosell et al, 1993), and tumour-suppressor
genes, specifically p53 (Horio et al, 1993). Alterations on short
tandem repeat DNA non-codifying sequences (microsatellites)
(Weber and May, 1989) are common in a gamut of human genetic
disorders. Although the function of these tandem repeats is not yet
clear, some researchers have speculated that such sequences may
be targets for certain proteins, which play a major role in the regu-
lation of gene expression and DNA recombination (Hamada et al,
1984; Berg et al, 1989). Microsatellite instability can be witnessed
as a change in the length of microsatellite sequences (expansions
or contractions) in tumour DNA compared with constitutional
DNA, but also as the complete loss of one or both alleles of the
repeat locus (LOH).
RERs are common in lung cancer and mostly localized on chro-
mosome 3p (Hibi et al, 1992; Shridhar et al, 1994; Wooster et al,
1994), but can be found on chromosome 2p (Merlo et al, 1994).
This is a little reported phenomenon in lung cancer (Fong et al,
1995; Ryberg et al, 1995), whereas widespread microsatellite insta-
bility commonly occurs in hereditary non-polyposis colorectal
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cancer (HNPCC)(Aaltonen et al, 1993; Thibodeau et al, 1993) and
other sporadic tumours, i.e. colorectal, endometrial and gastric
tumours (Lothe et al, 1993; Risinger et al, 1993; Mironov et al,
1994). The tumour phenotype displaying frequent RERs (Peinado et
al, 1992), which is characteristic of the Lynch syndrome and reflects
a defect in mismatch repair (Parsons et al, 1993), is not observed to
the same degree in other non-HNPCC tumours (Mao et al, 1994),
including lung cancer (Peltomaki et al, 1993; Merlo et al, 1994).
Sixty-four NSCLC patients were evaluated for evidence of
genomic instability at (CA)n dinucleotide repeats on chromosomes
Table 1 Clinicopathological characteristics of 64 NSCLCs according to
presence/absence of replications errors
Clinicopathological RER-positive tumours RER-negative tumours
characteristics n (%) n (%)
No. of patients 42 (66) 22 (34)
Age (years)
Median 62 59
Range 40-74 43-75
Sex
Male 40 (65) 22 (35)
Female 2
Histological type
Squamous cell carcinoma 26 (67) 13 (33)
Adenocarcinoma 12 (63) 7 (37)
Large-cell carcinoma 4 (67) 2 (33)
Stage
21 (66) 11 (34)
11 6 (50) 6 (50)
IIIA 15 (75) 5 (25)
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2p and 3p with three microsatellite markers on chromosome 2p and
five on chromosome 3p. Most of these microsatellite markers were
chosen near or within regions containing mismatch repair genes,
such as MSH2 on chromosome 2p and MLHI on chromosome 3p
(Hemminki et al, 1994; Liu et al, 1994; Parsons et al, 1995), or
thought to contain some tumour-suppressor genes. Furthermore,
mutations on K-ras and p53 genes were screened in order to estab-
lish plausible correlations between the presence or absence of
mutations and microsatellite instability. Our findings suggest that
RERs on microsatellite repeats located on chromosomes 2p and 3p
are frequent in NSCLC and indicates that p53 mutations and RER
changes are rare in the same NSCLC DNA samples, whereas
certain K-ras genotypes tend to be linked to RER changes. The
results of this study indicate that RERs may be prognostically
useful in defining the risk of relapse in NSCLC patients.
MATERIALS AND METHODS
Subjects
All 64 NSCLC patients had undergone thoracotomy and resection
between 1990 and 1991 as treatment of their disease. This period
was studied because post-operative adjuvant chemotherapy
was not employed routinely with patients at that time. Thus,
these NSCLCs represented a subset of lung tumours found in
patients with operable disease [stage I-IIIA, according to the
tumour-node-metastasis classification (Mountain, 1986)]. There
was no family history of hereditary non-polyposis colorectal
cancer in any case studied. Of the 64 patients in this study, two
were female and 62 were male with an average age of 61 years
(range 40-75 years). The patients' main characteristics are
summarized in Table 1. Patients were seen at 3 month intervals
during the first post-operative year, every 4 months during the
second and third year, and every 6 months thereafter. Follow-up
consisted of biochemical profile, chest radiograph and computer-
ized tomographic scan, and physical examination. Data on lung
cancer recurrence and causes of death were obtained.
DNA extraction
Microdissection of tumour and surrounding normal lung tissue
from 10-jim histology sections was performed as previously
described by McPherson et al (1991). DNA was quantified by
spectrophotometry and 100 ng of tissue were used in the poly-
merase chain reaction (PCR) analysis described below.
Analysis of microsatellite alterations
Microsatellite sequences are easy to assay using PCR (Jeffreys et
al, 1988). We performed a PCR assay using the corresponding
primer pair for each microsatellite marker. Microsatellite markers
analysed for each sample were D2S136 (2p4-pl3), D2S162
(2p25-p22) and D2S391 (2pl5) on chromosome 2p, and D3S1284
(3pl3-pl4), D3S1289 (3p2l.l-pl4.3), D3S1067 (3p2l.l-pl4.3),
D3S1038 (3p25) and D3S1611 (3p2l.3) on chromosome 3 and
were obtained as MapPairs (Research Genetics, Huntsville, AL,
USA). PCR was performed by 35 cycles of amplification in a final
volume of 20 jil using the following concentrations: 0.1 mM each
deoxynucleotide triphosphate, 0.1 gM each primer, 0.5 units of Taq
DNA polymerase (Perkin Elmer, Norwalk, CT, USA), 1.25 mM
magnesium chloride and 0.1 jIg of DNA template. PCR products
were radiolabelled incorporating 0.2 jiCi of [a32P]dCTP. For most
of the markers, PCR was carried out under the following condi-
tions: initially 1 min denaturing at 94°C, then 10 s denaturing at
94°C, 10 annealing at 55°C and 15 extension at 72°C for 35 cycles
with an additional 3 min extension for cycle 35 on a DNA Thermal
Cycler (Perkin Elmer Gene Amp PCR System 9600, Norwalk, CT,
USA). The DNA generated by PCR was characterized by agarose
gel electrophoresis. The PCR products were denatured by 96%
formamide and run on a 6% polyacrylamide gel containing 8 M
urea for 2-3 h at 40-45 W. The gels were dried and exposed to
radiographic film (X-OMAT-AR, Kodak, USA).
Analysis of K-ras and p53 gene mutations
Detection of mutations on K-ras oncogene was performed using
a PCR-SSCP assay and by PCR-allele-specific oligonucleotide
(ASO) hybridization to determine specific point mutations. For
the PCR-SSCP assay, PCR was performed using [OC32P]dCTP to
label amplified products directly. Amplification of ras-specific
sequences was performed as described (Rosell et al, 1993). K-ras
codons 12, 13 and 61 amplified radiolabelled products were elec-
trophoresed through 6% non-denaturing acrylamide gels at 4°C for
10-15 h at 4 W. Dried gels were then exposed to radiographic
films overnight at -80°C using intensifying screens. PCR-ASO
hybridization assay was performed as previously described (Rosell
et al, 1993). Mutations in exons 5-8 of the p53 gene were analysed
by means of PCR-SSCP using p53-specific primers. PCR-SSCP
assay was performed as for K-ras gene, while dideoxy sequencing
was as previously described (Sanger et al, 1977).
Statistical analysis
The primary statistical outcome in this study was overall survival
measured from the date of surgery. Survival curves were drawn for
each group of different variables, using the Kaplan-Meier method
(Kaplan and Meier, 1959), and differences among the curves were
computed by the log-rank statistic (Miller, 1981). The association
between RER-positive tumour DNAs and other genetic aberra-
tions with clinicopathological features was assessed using the chi-
square test. The most significant prognostic factors were identified
by the Cox proportional hazard method (Cox, 1972). The beta
regression coefficients presented for the multivariate analyses
indicate a relationship between a specific variable and overall
survival with the positive coefficient denoting an increased risk of
death and a negative coefficient denoting the opposite effect. All
P-values were based on two-sided comparisons. P-values of less
than 0.05 were considered to indicate statistical significance.
Table 2 Frequencies of replication errors and losses of heterozygosity for
each microsatellite marker studied
Marker RER LOH
n (%) n (%)
D2S162 13 (20) 3 (5)
D2S319 7 (11) 1 (2)
D2S136 12 (19) 1 (2)
D3S1 038 14 (22) 6 (9)
D3S1611 10 (16) 4 (6)
D3S1289 3( 5) 8(12.5)
D3S1067 7 (11) 3 (5)
D3S1284 7 (11) 5 (8)
British Journal of Cancer (1997) 75(2), 184-1890 Cancer Research Campaign 1997
186 A Pifarre et al
RESULTS
Microsatellite alterations for chromosomes 2p and 3p
A total of 512 analyses were performed, 73 (14%) of which were
positive. Of 64 cases of resected NSCLCs, 42 (66%) demonstrated
microsatellite instability (RER). RER incidence in the eight
microsatellite markers studied is shown in Table 2. Twenty
tumours (48%) showed RER in only one of the eight dinucleotide
repeat [(CA)n] markers tested. The remaining 22 tumours
evidenced RER in multiple scanned microsatellite markers
ranging from 15 patients (36%) whose tumours had RER in two of
the dinucleotide markers tested to tumours in five patients, which
showed RER in three screened microsatellite markers. Two
patients showed RER in more than three of the polymorphic
markers tested. Representative results of the RER analysis are
shown in Figure 1. Microsatellite marker alterations were more
often observed at the D2S162 (2p25-p22) locus on chromosome
2p and the D3S1038 (3p25) locus on chromosome 3p (20% and
22% of RERs in both microsatellite markers). Microsatellite insta-
bility was also recorded in D2S391 (2pl5, near M'SH2 mismatch
repair gene) and D3S 1611 (3p21.3, within MLHI mismatch repair
gene) with 11% and 16% incidence respectively. No significant
marker-related survival differences were found, but the number of
markers altered appeared to be relevant, as the higher the number
of alterations the shorter the survival. There was no significant
correlation between RER and clinicopathological data (Table 1).
Microsatellite instability was found (1) in all histological subtypes,
squamous cell carcinoma (26 cases), adenocarcinoma (12 cases)
and large-cell carcinoma (four cases); and (2) at all tumour stages,
stage I (21 cases), stage II (six cases) and stage III (15 cases).
Similar age and tumour size (T1-T3) distribution were noted in
both the groups with or without RERs.
Correlation with LOH at chromosomes 2p and 3p
We examined the association between the presence of RERs and
LOH. Allelic loss was observed in 23 of the 64 tumour specimens
(36%), at 6% of the loci screened. The incidence of LOH at the
loci examined is shown in Table 2. Overall, the frequency of 2p
LOH and 3p LOH was not significantly different in RER-negative
tumours (50%) in comparison with RER-positive tumours (28.5%)
(Table 3).
Correlation with K-ras and p53 gene mutations
RER occurred in combination with other genetic aberrations in this
cohort of patients. The incidence of K-ras gene mutations was no
different in RER-positive tumours (21%) than in RER-negative
tumours (18%, P = 0.51), although differences surfaced in stage I,
K-ras mutations according to specific genotypes at codon 12
(Rosell et al, 1993). There was a trend in the RER-positive group
to contain aspartic and serine substitutions instead of the wild-type
glycine, which was not observed in the RER-negative group.
Valine codon 12 mutations were commonly observed in RER-
negative tumours but not seen in RER-positive tumours. In addi-
tion, p53 gene mutations were detected in 13 of 42 (31 %)
RER-positive tumours and were higher in the RER-negative group
(50%, Table 3), although the difference was statistically significant
only in stage I, with 3 of 20 (15%) RER-positive tumours in
contrast to 6 of 11 (54.5%) RER-negative tumours (P = 0.02).
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Figure 1 Representative polymerase chain reaction products of CA
microsatellite repeats in NSCLC. The microsatellite markers were amplified
from normal (N) DNA and microdissected tumour tissue (T). Patients 6 and 7
show allelic imbalance (arrows, both contraction and expansion respectively)
for the D3S1067 marker. Patients 15 and 18 show loss of heterozygosity
(arrowheads) for the D3S1289 marker
Table 3 Association of replication error presence with K-ras and p53
mutations and presence/absence of loss of heterozygosity in 64 NSCLC
patients
Genetic RER-positive tumours RER-negative tumours P-value
changes n(%) n(%)
No. of patients 42 (66) 22 (34)
K-ras
Mutated 9 (21) 4 (18) 0.51
Non-mutated 33 (79) 18 (82)
p53
Mutated 13(31) 11 (50) 0.11
Non-mutated 29 (69) 11 (50)
LOH
Present 12 (28.5) 11 (50) 0.07
Absent 30 (71.5) 11 (50)
Microsatellite alterations and survival
The median follow-up for the 64 patients was 30 months. The five-
year survival rate was 80% in patients with stage I disease whose
tumours had no RER and 26% in patients with the same stage
whose tumours had RER; moreover, the difference in survival
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Figure 2 Survival probability in patients with resected stage NSCLC and
either replication error-positive or replication error-negative tumours
Table 4 Survival-related variables in 64 patients according to the Cox
proportional hazard model
Variable Categories Hazard ratio 95% confidence P-value
compareda interval
RER +/- 2.89 2.23-3.79 0.002
Stage IIIA vs 11 vs 1.32 0.99-1.65 0.08
aFor each variable, the prognostic significance of the first category listed was
assessed by comparing that category with the reference category (the
second category listed).
curves was significant (P = 0.005) (Figure 2). Similar results
were obtained when disease-free survival was the end point.
Furthermore, in the group of patients with microsatellite alter-
ations on more than two dinucleotide markers, there was still
poorer outcome with no long-term survivors. To identify the most
powerful prognostic factors, we performed multivariate analyses
with Cox proportional hazards model. The hazards ratios were
calculated using two models with clinicopathological factors inter-
related with K-ras and p53 gene mutations, LOH and RER pheno-
type. The first model combined tumour stage, histology, K-ras and
p53 mutations, LOH and RER presence or absence. The second
model combined tumour stage and RER phenotype because the
combination gave the best fit attainable with any of the prognostic
factors combination (Table 4). The presence of RER yielded a
hazard ratio of 2.89 (95% confidence interval, 2.23-3.79; P =
0.002). On the other hand, patients with LOH-positive tumours
also tended to show a worse outcome, but these results did not
reach statistical significance (P = 0.07).
DISCUSSION
The main objectives of this study were to determine whether
patients with NSCLC had frequent microsatellite instability of
(CA)n repeats on chromosomes 2p and 3p and to explore the
importance of RER phenotype as a prognostic marker in resected
NSCLC. Most patients in this study (66%) showed RER in at least
one of the eight dinucleotide repeat markers examined. Recent
cytogenetic and molecular studies have elucidated the fragility of
chromosome 3p in a number of primary NSCLC tumours as well as
in small-cell lung cancer (SCLC)(Hibi et al, 1992; Horio et al,
1993; Ryberg et al, 1995). Shridhar et al (1994) have documented
frequent RERs (13 of 38, 34%) in NSCLC tumours using ten
microsatellite markers on chromosome 3p. These findings are
strikingly different from a former study in which RERs were
present in only 2% of 86 lung tumours analysed (Peltomaki et
al, 1993). This low frequency could be attributed to the fact that
only one of the eight microsatellite markers screened was derived
from chromosome 3, D3S1266 (3p24-p25). On reassessing the
microsatellite instability of these patients using four different
markers from chromosome 3p, 21 % were found to have changes in
at least one microsatellite locus (Ryberg et al, 1995). In a recent
study (Fong et al, 1995), RER was also an infrequent event,
affecting only seven of 108 lung tumours (6.5%), reflecting once
more the fact that no microsatellite markers on chromosome 3p
were tested and only one on chromosome 2p. Ryberg et al (1995)
have shown that there are several factors that may influence the
frequency of the NSCLC microsatellite instability found, such as
the number of loci studied and their location, as well as the selec-
tion of patients. This confers the ability to induce microsatellite
instability to factors other than mismatch repair defects defined in
HNPCC, at least as far as chromosome 3p in lung cancer is
concerned. In this study, as in SCLC (Merlo et al, 1994), we found
that microsatellites markers analysed on chromosome 2p were
frequent targets for RER in this kind of tumour. These results indi-
cate that the RER phenomenon is not as widespread in NSCLC as
it is in tumours from HNPCC kindreds, and that both chromosomes
2p and 3p may be hotspots for RER in lung cancer. One or several
tumour-suppressor genes potentially able to alter microsatellite
stability may be harboured on these chromosome arms.
Genetic instability is likely to increase the activation of loci,
which directly contribute to tumorigenesis (Loeb, 1994), although
p53 or K-ras do not appear to be among these loci. p53 mutations
and the presence of RER, revealed by (CA)n repeat alterations, act
through distinct pathways, since these changes are not observed
simultaneously in the same tumour, as described in gastric cancer
(Mironov et al, 1994) and in the present NSCLC study. Our
patients with stage I RER tumours had a significantly higher p53
rate without mutations than did those with RER-negative tumours
(81 % vs 45%). Surprisingly, a worse outcome was seen in patients
without p53 mutations when compared with patients whose
tumours had p53 mutations. This biological behaviour could be
explained partly by the higher rate of RER-positive tumours in
those without p53 mutations, indicating that some other factors
intimately related to RER could confer higher aggressiveness to
NSCLCs. These findings concur with the data of other authors
(Ryberg et al, 1994), who found no correlation between p53 muta-
tions and the presence of rare alleles; the latter related to a higher
incidence of microsatellite instability (Ryberg et al, 1995). The
prevalence of K-ras mutations was not significantly different
according to RER phenotype. However, in patients with stage I
RER-positive tumours, there was a tendency to have aspartic
and serine codon 12 K-ras mutations, which are said to confer
more tumour aggressiveness (Rosell et al, 1994), while valine
codon 12 mutations, which have less virulent behaviour, were
linked to stage I RER-negative tumours, although the differences
were not significant.
This particular type of genetic error may well result from
defective DNA repair genes located on chromosomes 2p and 3p
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(MSH2 and MLHI), possibly along with other similar genes
(Hemminki et al, 1994; Liu et al, 1994; Parsons et al, 1995;
Gleeson et al, 1996). However, other investigators have defined
novel mechanisms involving greater repetitive DNA regions (vari-
able number of tandem repeats), such as the presence of rare
constitutional alleles of the H-ras I minisatellite locus, which are
linked to a higher risk of developing cancer (Krontiris et al, 1993;
Ryberg et al, 1995). Moreover, mechanisms involving cell oxida-
tive stress in mismatch repair system failure have also been
suggested (Brentnall et al, 1995), indicating deficient pathways
other than mismatch repair gene defects.
To our knowledge, this is the first study in which survival
analysis has been carried out according to RER phenomenon in
NSCLC and our data indicate firstly, that, RER occurs frequently
in NSCLC (66%) and, secondly, that RER-positive tumours are
linked to worse survival and may be an independent predictor of
poor outcome in NSCLC patients who undergo surgery. In addi-
tion, the presence of RERs is not related to p53 mutations and the
absence of the prognostic value of p53 mutations suggests that
other undetected changes in RER tumours may be implicated in
NSCLC. Furthermore, the relatively high proportion of patients
with RER-positive tumours who have no LOH or K-ras mutations
prompts us to propose that RERs could be a new relevant prog-
nostic marker in the early stages of NSCLC.
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